ConductScience.org, home

Paper42576759

[Preliminary investigation into the mechanisms of thalidomide in inhibiting the malignant transformation of oral leukoplakia].

Shang Q and 4 others. Hua Xi Kou Qiang Yi Xue Za Zhi, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. [Preliminary investigation into the mechanisms of thalidomide in inhibiting the malignant transformation of oral leukoplakia]. Papers, record 42576759. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42576759

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Preliminary investigation into the mechanisms of thalidomide in inhibiting the malignant transformation of oral leukoplakia].
PubMed
Journal
Hua Xi Kou Qiang Yi Xue Za Zhi
PubMed
Year
2026
PubMed
Publication types
English Abstract, Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shang QQianhui
2Awuti GGulinuer
3Xu HHao
4Chen QQianming
5Zhao JJin

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ThalidomideMajor topic
Cell Transformation, NeoplasticMajor topic
Leukoplakia, OralMajor topic
Humans
Molecular Docking Simulation
Signal Transduction
Protein Interaction Maps
DNA (Cytosine-5-)-Methyltransferase 1
Poly (ADP-Ribose) Polymerase-1
Network Pharmacology
Proto-Oncogene Mas

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135152645[Guideline for the diagnosis and treatment of oral lichen planus (revision)].Zhonghua Kou Qiang Yi Xue Za Zhi2022https://conductscience.org/library/papers/35152645PubMed
234982498Oral leukoplakia: A clinicopathological study and malignant transformation.Oral Dis2023https://conductscience.org/library/papers/34982498PubMed
333993200Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours.Oncogenesis2021https://conductscience.org/library/papers/33993200PubMed
436430388MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies.Int J Mol Sci2022https://conductscience.org/library/papers/36430388PubMed
538503157c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.Phytomedicine2024https://conductscience.org/library/papers/38503157PubMed
623318436Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy.Oncogene2013https://conductscience.org/library/papers/23318436PubMed
739290142Recurrence in Oral Leukoplakia: A Systematic Review and Meta-analysis.J Dent Res2024https://conductscience.org/library/papers/39290142PubMed
828676700The multifaceted roles of PARP1 in DNA repair and chromatin remodelling.Nat Rev Mol Cell Biol2017https://conductscience.org/library/papers/28676700PubMed
933451333Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy.Mol Cancer2021https://conductscience.org/library/papers/33451333PubMed
1035236826Downregulation of MUC15 by miR-183-5p.1 promotes liver tumor-initiating cells properties and tumorigenesis via regulating c-MET/PI3K/AKT/SOX2 axis.Cell Death Dis2022https://conductscience.org/library/papers/35236826PubMed
1139239507Single-cell RNA sequencing highlights the immunosuppression of IDO1+ macrophages in the malignant transformation of oral leukoplakia.Theranostics2024https://conductscience.org/library/papers/39239507PubMed
1237752089Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside.J Zhejiang Univ Sci B2023https://conductscience.org/library/papers/37752089PubMed
1341123100Decoding Spatiotemporal Microenvironmental Changes in Oral Carcinogenesis.J Dent Res2026https://conductscience.org/library/papers/41123100PubMed
1433217066The genetic basis of oral leukoplakia and its key role in understanding oral carcinogenesis.J Oral Pathol Med2021https://conductscience.org/library/papers/33217066PubMed
1529991692Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis.Sci Rep2018https://conductscience.org/library/papers/29991692PubMed
1634165402Recent Advances in the Development of Thalidomide-Related Compounds as Anticancer Drugs.Curr Med Chem2022https://conductscience.org/library/papers/34165402PubMed
1739314164Malignant transformation of oral leukoplakia: Systematic review and comprehensive meta-analysis.Oral Dis2025https://conductscience.org/library/papers/39314164PubMed
1835081970Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer.Mol Cancer2022https://conductscience.org/library/papers/35081970PubMed
1922704061Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma.Oral Oncol2012https://conductscience.org/library/papers/22704061PubMed
2025156040Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial.Int J Cancer2015https://conductscience.org/library/papers/25156040PubMed

See all 28 referencesDownload CSV of references

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42576759

GET https://conductscience.org/api/papers/v1/42576759/references?page=2